Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Vaccines

Free Subscription 11.03.2024 2 BMJ 1 J Infect 4 J Infect Dis 2 J Virol 1 JAMA 2 MMWR Morb Mortal Wkly Rep 1 Nat Immunol 1 Nat Med 2 Pediatr Infect Dis J 9 PLoS One 2 Science 13 Vaccine

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMJ

1. FISHER M
   Understanding the history of vaccine hesitancy and current mistrust in healthcare.
   BMJ. 2024;384:q539.
   PubMed        
   
   
2. MAJEED A
   Increasing measles, mumps, and rubella (MMR) vaccine uptake in primary care.
   BMJ. 2024;384:q552.
   PubMed        
   
   

   
   J Infect

3. FATLY ZA, Betjes MGH, Dik WA, Fouchier RAM, et al
   Mycophenolate mofetil hampers antibody responses to a broad range of vaccinations in kidney transplant recipients: results from a randomized controlled study.
   J Infect. 2024 Mar 1:106133. doi: 10.1016/j.jinf.2024.106133.
   PubMed         Abstract available
   
   

   
   J Infect Dis

4. LIM WW, Shuo F, Wong SS, Sullivan SG, et al
   Hemagglutination inhibition antibody titers mediate influenza vaccine efficacy against symptomatic influenza A(H1N1), A(H3N2), and B/Victoria infections.
   J Infect Dis. 2024 Mar 7:jiae122. doi: 10.1093.
   PubMed         Abstract available
   
   
5. COLON W, Oriol Mathieu V, Hural J, Hattingh L, et al
   HIV Diagnostics and Vaccines: It Takes Two to Tango.
   J Infect Dis. 2024 Mar 7:jiae113. doi: 10.1093.
   PubMed         Abstract available
   
   
6. WESTERCAMP N, Osei-Tutu L, Schuerman L, Kariuki SK, et al
   Could less be more? Accounting for fractional-dose regimens and different number of vaccine doses when measuring the impact of the RTS, S/AS01E malaria vaccine.
   J Infect Dis. 2024 Mar 4:jiae075. doi: 10.1093.
   PubMed         Abstract available
   
   
7. CHONG EA, Kumashie KG, Chong ER, Fabrizio J, et al
   Immunologic predictors of vaccine responsiveness in patients with lymphoma and CLL.
   J Infect Dis. 2024 Mar 4:jiae106. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   J Virol

8. HSIEH M-S, Hsu C-W, Liao H-C, Lin C-L, et al
   SARS-CoV-2 spike-FLIPr fusion protein plus lipidated FLIPr protects against various SARS-CoV-2 variants in hamsters.
   J Virol. 2024 Feb 1:e0154623. doi: 10.1128/jvi.01546.
   PubMed         Abstract available
   
   
9. ROWE T, Davis W, Wentworth DE, Ross T, et al
   Differential interferon responses to influenza A and B viruses in primary ferret respiratory epithelial cells.
   J Virol. 2024 Jan 31:e0149423. doi: 10.1128/jvi.01494.
   PubMed         Abstract available
   
   

   
   JAMA

10. HARRIS E
    HPV Vaccination Rates Stagnated During COVID-19 Pandemic.
    JAMA. 2024 Mar 6. doi: 10.1001/jama.2024.1569.
    PubMed        
    
    

    
    MMWR Morb Mortal Wkly Rep

11. MOLINE HL, Tannis A, Toepfer AP, Williams JV, et al
    Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus-Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season - New Vaccine Surveillance Network, October 2023-February 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:209-214.
    PubMed         Abstract available
    
    
12. OU AC, Zimmerman LA, Alexander JP Jr, Crowcroft NS, et al
    Progress Toward Rubella and Congenital Rubella Syndrome Elimination - Worldwide, 2012-2022.
    MMWR Morb Mortal Wkly Rep. 2024;73:162-167.
    PubMed         Abstract available
    
    

    
    Nat Immunol

13. TRAN KA, Pernet E, Sadeghi M, Downey J, et al
    BCG immunization induces CX3CR1(hi) effector memory T cells to provide cross-protection via IFN-gamma-mediated trained immunity.
    Nat Immunol. 2024;25:418-431.
    PubMed         Abstract available
    
    

    
    Nat Med

14. XU H, Zou K, Dent J, Wiens KE, et al
    Enhanced cholera surveillance to improve vaccination campaign efficiency.
    Nat Med. 2024 Mar 5. doi: 10.1038/s41591-024-02852.
    PubMed         Abstract available
    
    

    
    Pediatr Infect Dis J

15. PLOTKIN SA
    We Need a New Mumps Vaccine.
    Pediatr Infect Dis J. 2024;43:350.
    PubMed        
    
    
16. KORBAL P, Wysocki J, Jackowska T, Kline M, et al
    Phase 3 Safety and Immunogenicity Study of a Three-dose Series of Twenty-valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers.
    Pediatr Infect Dis J. 2024 Mar 8. doi: 10.1097/INF.0000000000004300.
    PubMed         Abstract available
    
    

    
    PLoS One

17. SCHRIJVERS-GONLAG M, Skarpe C, Julkunen-Tiitto R, Poleo ABS, et al
    Phenolic concentrations and carbon/nitrogen ratio in annual shoots of bilberry (Vaccinium myrtillus) after simulated herbivory.
    PLoS One. 2024;19:e0298229.
    PubMed         Abstract available
    
    
18. KECHAGIAS KS, Laleye JD, Drmota J, Geropoulos G, et al
    Minimal change disease following COVID-19 vaccination: A systematic review.
    PLoS One. 2024;19:e0297568.
    PubMed         Abstract available
    
    
19. WILLIAMS SV, Akande T, Abbas K
    Systematic review of social determinants of childhood immunisation in low- and middle-income countries and equity impact analysis of childhood vaccination coverage in Nigeria.
    PLoS One. 2024;19:e0297326.
    PubMed         Abstract available
    
    
20. MALITA MA, Manolescu LSC, Perieanu VS, Babiuc I, et al
    COVID-19 and flu vaccination in Romania, post pandemic lessons in healthcare workers and general population.
    PLoS One. 2024;19:e0299568.
    PubMed         Abstract available
    
    
21. AGIMAS MC, Alemayehu MA, Derseh NM, Aragaw FM, et al
    Correction: Spatial pattern and associated factors of timely vaccination in Ethiopia using EDHS-2016 data: A multilevel and spatial analysis.
    PLoS One. 2024;19:e0300482.
    PubMed         Abstract available
    
    
22. ZHANG X, Han X, Chen B, Fu X, et al
    Influence of nutritional supplements on antibody levels in pregnant women vaccinated with inactivated SARS-CoV-2 vaccines.
    PLoS One. 2024;19:e0289255.
    PubMed         Abstract available
    
    
23. GIANNOUCHOS TV, Hair NL, Olatosi B, Li X, et al
    Waning effectiveness of mRNA COVID-19 vaccines against inpatient and emergency department encounters.
    PLoS One. 2024;19:e0300198.
    PubMed         Abstract available
    
    
24. TANNER AE, Hall MA, Aguilar-Palma SK, Mann-Jackson L, et al
    Understanding uptake of COVID-19 testing, vaccination, and boosters among Spanish-speaking Latines in the United States: Qualitative insights from Spanish speakers and key informants.
    PLoS One. 2024;19:e0296812.
    PubMed         Abstract available
    
    
25. SENJAM SS, Manna S, Goel G, Balhara YPS, et al
    Vaccination coverage against COVID-19 among rural population in Haryana, India: A cross-sectional study.
    PLoS One. 2024;19:e0299564.
    PubMed         Abstract available
    
    

    
    Science

26. COHEN J
    Skin side effects stymie advance of HIV vaccine.
    Science. 2024;383:1044.
    PubMed         Abstract available
    
    
27. TRIUNFOL M
    Brazil is hoping and waiting for a new vaccine as dengue rages.
    Science. 2024;383:1042-1043.
    PubMed         Abstract available
    
    

    
    Vaccine

28. DUAN X, Zhang L, Ding L, Zhang C, et al
    Effectiveness of enterovirus A71 vaccine against pediatric HFMD and disease profile of post-vaccination infection.
    Vaccine. 2024 Mar 2:S0264-410X(24)00172-5. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
29. ZAMAN K, Schuind AE, Adjei S, Antony K, et al
    Safety and immunogenicity of Innovax bivalent human papillomavirus vaccine in girls 9-14 years of age: Interim analysis from a phase 3 clinical trial.
    Vaccine. 2024 Mar 1:S0264-410X(24)00251-2. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
30. YASHAR-GERSHMAN SG, Rosenberg AT, Sawhney M, Fernanda Machicao M, et al
    Developing a novel screening tool to address pediatric COVID-19 vaccine hesitancy at point of care.
    Vaccine. 2024 Mar 1:S0264-410X(24)00228-7. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
31. KOHLI M, Maschio M, Lee A, Igarashi A, et al
    Projections of the incidence of COVID-19 in Japan and the potential impact of a Fall 2023 COVID-19 vaccine.
    Vaccine. 2024 Feb 29:S0264-410X(24)00117-8. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
32. CHATHAM-STEPHENS K, Carter RJ, Duggar C, Woodworth KR, et al
    An overview of the COVID-19 pediatric vaccine program - The U.S. experience vaccinating children ages 6 months through 17 years.
    Vaccine. 2024 Feb 29:S0264-410X(24)00166-X. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
33. BEAVIS AC, Dienger-Stambaugh K, Briggs K, Chen Z, et al
    A J Paramyxovirus-vectored HIV vaccine induces humoral and cellular responses in mice.
    Vaccine. 2024 Mar 4:S0264-410X(24)00227-5. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
34. MARQUES RF, Gimenez AM, Caballero O, Simpson A, et al
    Non-clinical toxicity and immunogenicity evaluation of a Plasmodium vivax malaria vaccine using Poly-ICLC (Hiltonol(R)) as adjuvant.
    Vaccine. 2024 Mar 5:S0264-410X(24)00229-9. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
35. RAETHKE M, van Hunsel F, Luxi N, Lieber T, et al
    Frequency and timing of adverse reactions to COVID-19 vaccines; A multi-country cohort event monitoring study.
    Vaccine. 2024 Mar 6:S0264-410X(24)00273-1. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
36. CHEN D, Cowling BJ, Ainslie KEC, Lin Y, et al
    Association of COVID-19 vaccination with duration of hospitalization in older adults in Hong Kong.
    Vaccine. 2024 Mar 5:S0264-410X(24)00252-4. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
37. WONG WHS, Leung DL, Yip KM, So HK, et al
    Effectiveness of inactivated COVID-19 vaccine CoronaVac in children aged less than 3 years old during Omicron wave in Hong Kong.
    Vaccine. 2024 Mar 6:S0264-410X(24)00226-3. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
38. KARRAS J, Harrison M, Steffens M, Abdi I, et al
    "COVID is a huge jigsaw puzzle that I am trying to make sense of myself": Exploring the perceptions towards the COVID-19 vaccine communication strategy in Australia amongst unvaccinated Australian adults.
    Vaccine. 2024 Mar 6:S0264-410X(24)00276-7. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
39. GHASEMIFAR S, Chabak O, Piri-Gharaghie T, Doosti A, et al
    PIRES2-EGFP/CTB-UreI vaccination activated a mixed Th1/Th2/Th17 immune system defense towards Helicobacter pylori infection in the BALB/c mice model.
    Vaccine. 2024 Mar 7:S0264-410X(24)00209-3. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
40. MENG L, Harris L, Shaw L, Lymon H, et al
    Social and demographic factors associated with receipt of a COVID-19 vaccine initial booster dose and with interval between primary series completion and initial booster dose uptake among persons aged >/= 12 years, United States, August 2021-October 2
    Vaccine. 2024 Mar 6:S0264-410X(24)00271-8. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.